By the end of a request period, the Commission acting as secretariat of the Coordination Group (‘HTA secretariat’) shall perform the following actions:
make available through the HTA IT platform the requests for joint scientific consultations on medical devices and in vitro diagnostic medical devices complying with the requirements in Article 3(1), second subparagraph, to the subgroup on joint scientific consultations of the Coordination Group (‘JSC Subgroup’) and indicate for which of those requests relating to medical devices, the expert panel consultation has been requested to be carried out in parallel;
share with the European Medicines Agency the list of requests for joint scientific consultation on medical devices for which the health technology developer indicated that it is requesting the expert panel consultation to be carried out in parallel.
Within 15 working days after the end of each request period, the HTA secretariat shall inform the European Medicines Agency which of the requests referred to in paragraph 1, point (b), were selected for joint scientific consultation and the European Medicines Agency shall inform the HTA secretariat which of the requests for the expert panel consultation to be carried out in parallel, in accordance with paragraph 1, point (b), were accepted.